Dr. Michelle Deschamplain, MD

Dr. Deschamplain practices at Manatee Memorial Hospital in Bradenton, Florida, part of Universal Health Services.

Dr. Deschamplain's NPI, 1952510299, was assigned on May 22, 2007. Dr. Deschamplain graduated from VCU School of Medicine in 2003. Dr. Deschamplain holds Florida license ME150243.

Dr. Deschamplain's primary practice is Manatee Memorial Hospital, at 206 2nd St E, Bradenton, FL 34208 in Manatee County. The practice phone is (941) 746-5111.

Dr. Deschamplain's primary practice is Manatee Memorial Hospital in Bradenton, Florida, part of Universal Health Services. Dr. Deschamplain is also affiliated with Mercy Health - St. Rita's Medical Center. The medical group on file is Manatee Physician Alliance. Dmand AI also links Dr. Deschamplain to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Deschamplain practices, 3 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Deschamplain's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Deschamplain is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Deschamplain's licenses on file in 5 states: Florida, Virginia, Georgia, South Carolina and Pennsylvania.

Dmand AI lists amputation, aortic atherosclerois, blood vessel access for dialysis, carotid revascularization, chronic skin ulcer, deep vein thrombosis (DVT), heart device and aorta surgery and leg revascularization among the conditions Dr. Deschamplain treats.

CMS data shows 315 Medicare services from Dr. Deschamplain across 10 procedure codes in 2024, for 203 Medicare patients. Medicare paid $26,129 for them.

CMS counts 203 Medicare patients who saw Dr. Deschamplain in 2024. The largest group is 65 to 74, with 81 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Deschamplain's median patient age at 69, with 42% women.

In 2024, Dr. Deschamplain wrote 202 Medicare Part D claims for 74 patients. 92% of them were for generic drugs. CMS names the drug for 133 of them, across 2 drugs with 11 or more claims each, at $803 in total drug cost. In 2023, CMS named 85 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Deschamplain for performance year 2024, reported through an alternative payment model (APM). Dr. Deschamplain accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Deschamplain. Dr. Deschamplain's most frequent co-authors are Derek R. Brinster, MD and Rajesh Ramanathan, MD.

CMS Open Payments shows 343 general payments to Dr. Deschamplain from 43 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 58% of the total. Medtronic, Inc. paid the most, $8,734.

Dmand AI lists 2 awards for Dr. Deschamplain, most recently CMS Stage 1 EHR in 2013.

Dr. Deschamplain graduated from VCU School of Medicine in 2003. Dr. Deschamplain is a member of ACS and SVS.

Dr. Deschamplain is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.